Metabolomics Biomarkers of Neurodegeneration

Client

Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 65,000+ dedicated people, including more than 12,000 physicians and advanced practice providers and more than 15,500 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, and Priority Health, a provider-sponsored health plan serving more than 1.3 million members.

Background

Identify small molecules that could be used for diagnostics of various neurological conditions and neurodegenerative disorders.

Solutions

  • Targeted and untargeted mass spectrometry data processing pipeline
  • Integration of metabolomics, epigenomics and other data sources
  • AI-based predictors for diagnostics and identification of novel therapeutic targets

Publications

Scientific Reports, read full article: Link
Genes, read full article: Link

Cover image credits: Anusorn / Adobe Stock

Similar Resources

News, Success stories
August 5, 2026

How VUGENE Is Turning Massive Life Science Datasets into Biological Insights

Today’s science involves less white lab coats and observations jotted into notebooks and more automated laboratory systems generating millions – if not billions – of data points that are then ...

Corewell Health
Success stories
August 3, 2026

How VUGENE Is Helping Researchers Identify Who Is Most Likely to Develop Alzheimer’s Disease

WATCH – Customer success story | Corewell Health Background Alzheimer’s disease is the seventh leading cause of death in the world, and it is estimated that by 2030, 78 million ...